106
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Sex-Specific Differences in the Clinical Profile Among Patients with Tracheobronchial Tuberculosis: A Hospital-Based Cross-Sectional Study in Shenzhen, China

, , ORCID Icon, , , , ORCID Icon, & show all
Pages 5741-5750 | Published online: 21 Jun 2022

References

  • Weil D, Marinkovic K, Kasaeva T. Back to the future, again: greater leadership, collaboration and accountability to accelerate progress to end TB. BMC Med. 2018;16(1):172. doi:10.1186/s12916-018-1165-9
  • World Health Organization. Global tuberculosis report 2020; 2020. Available from: https://www.who.int/publications/i/item/global-tuberculosis-report-2020. Accessed June 7, 2022.
  • Pathak V, Shepherd RW, Shojaee S. Tracheobronchial tuberculosis. J Thorac Dis. 2016;8(12):3818–3825. doi:10.21037/jtd.2016.12.75
  • Shim YS. Endobronchial tuberculosis. Respirology. 1996;1(2):95–106. doi:10.1111/j.1440-1843.1996.tb00017.x
  • Jung SS, Park HS, Kim JO, Kim SY. Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis. Respirology. 2015;20(3):488–495. doi:10.1111/resp.12474
  • Shahzad T, Irfan M. Endobronchial tuberculosis-A review. J Thorac Dis. 2016;8(12):3797–3802. doi:10.21037/jtd.2016.12.73
  • Siow WT, Lee P. Tracheobronchial tuberculosis: a clinical review. J Thorac Dis. 2017;9(1):E71–77. doi:10.21037/jtd.2017.01.49
  • Faisal M, Harun H, Hassan TM, Ban A, Chotirmall SH, Rahaman JA. Treatment of multiple-level tracheobronchial stenosis secondary to endobronchial tuberculosis using bronchoscopic balloon dilatation with topical mitomycin-C. BMC Pulm Med. 2016;16(1):53. doi:10.1186/s12890-016-0209-1
  • Kashyap S, Solanki A. Challenges in endobronchial tuberculosis: from diagnosis to management. Pulm Med. 2014;2014:594806. doi:10.1155/2014/594806
  • Peng AZ, Yang A, Li SJ, Qiu Q, Yang S, Chen Y. Incidence, laboratory diagnosis and predictors of tracheobronchial tuberculosis in patients with pulmonary tuberculosis in Chongqing, China. Exp Ther Med. 2020;20(6):174. doi:10.3892/etm.2020.9304
  • Lee JH, Park SS, Lee DH, Shin DH, Yang SC, Yoo BM. Endobronchial tuberculosis. Clinical and bronchoscopic features in 121 cases. Chest. 1992;102(4):990–994. doi:10.1378/chest.102.4.990
  • Lee JH, Lee DH, Park SS. Endobronchial tuberculosis: clinical and bronchofiberscopic features. Korean J Intern Med. 1986;1(2):229–232. doi:10.3904/kjim.1986.1.2.229
  • Carlen R. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis. 1991;143(4 Pt 1):895–896. doi:10.1164/ajrccm/143.4_Pt_1.895
  • Chinese Medical Association. Diagnosis and treatment guideline for tracheobronchial tuberculosis. Chin J Tuberc Respir Dis. 2012;35:581–587.
  • World Health Organization. Definitions and Reporting Framework for Tuberculosis-2013 Revision. Geneva: World Health Organization; 2013.
  • Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697–722. doi:10.1148/radiol.2462070712
  • Lee P. Endobronchial tuberculosis. Indian J Tuberc. 2015;62(1):7–12. doi:10.1016/j.ijtb.2015.02.002
  • Su Z, Cheng Y, Wu Z, et al. Incidence and predictors of tracheobronchial tuberculosis in pulmonary tuberculosis: a multicentre, large-scale and prospective study in Southern China. Respiration. 2019;97(2):153–159. doi:10.1159/000492335
  • Rikimaru T, Kinosita M, Yano H, et al. Diagnostic features and therapeutic outcome of erosive and ulcerous endobronchial tuberculosis. Int J Tuberc Lung Dis. 1998;2(7):558–562.
  • Cheng J, Zhang H, Zhao YL, Wang LX, Chen MT. Mutual impact of diabetes mellitus and tuberculosis in China. Biomed Environ Sci. 2017;30(5):384–389. doi:10.3967/bes2017.051
  • Ayelign B, Negash M, Genetu M, Wondmagegn T, Shibabaw T. Immunological impacts of diabetes on the susceptibility of mycobacterium tuberculosis. J Immunol Res. 2019;2019:6196532. doi:10.1155/2019/6196532
  • Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152. doi:10.1371/journal.pmed.0050152
  • Ozma MA, Rashedi J, Poor BM, et al. Tuberculosis and diabetes mellitus in Northwest of Iran. Infect Disord Drug Targets. 2020;20(5):667–671. doi:10.2174/1871526519666190715142100
  • Sahin F, Yıldız P. Characteristics of endobronchial tuberculosis patients with negative sputum acid-fast bacillus. J Thorac Dis. 2013;5(6):764–770. doi:10.3978/j.issn.2072-1439.2013.12.15
  • Donath J, Khan FA. Tuberculous and posttuberculous bronchopleural fistula. Ten year clinical experience. Chest. 1984;86(5):697–703. doi:10.1378/chest.86.5.697
  • Jia L, Chen H, Huang H, Shen L. Clinical analysis and early diagnosis on 32 tracheobronchial tuberculosis induced by lymphatic fistula. J Clin Pulm Med. 2017;22(12):2248–2252.
  • O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475–527. doi:10.1146/annurev-immunol-032712-095939
  • Chegou NN, Sutherland JS, Malherbe S, et al. Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB. Thorax. 2016;71(9):785–794. doi:10.1136/thoraxjnl-2015-207999
  • Shapiro AE, Hong T, Govere S, et al. C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa. AIDS. 2018;32(13):1811–1820. doi:10.1097/QAD.0000000000001902
  • Xu Y, Cheng M, Wang X. C-reactive protein +1444C/T polymorphism is associated with the susceptibility to pulmonary tuberculosis. Biomed Res Int. 2020;2020:6634879. doi:10.1155/2020/6634879
  • Sun W, Jiao L, Liu T, et al. No significant effects of IL-6 and IL-13 gene variants on tuberculosis susceptibility in the Chinese population. DNA Cell Biol. 2020;39(7):1356–1367. doi:10.1089/dna.2020.5404
  • Masuda K, Ripley B, Nishimura R, et al. Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo. Proc Natl Acad Sci U S A. 2013;110(23):9409–9414. doi:10.1073/pnas.1307419110
  • Shah JA, Musvosvi M, Shey M, et al. A functional toll-interacting protein variant is associated with Bacillus Calmette-Guérin-specific immune responses and tuberculosis. Am J Respir Crit Care Med. 2017;196(4):502–511. doi:10.1164/rccm.201611-2346OC
  • Gupte AN, Kumar P, Araújo-Pereira M, et al. Baseline IL-6 is a biomarker for unfavorable tuberculosis treatment outcomes: a multi-site discovery and validation study. Eur Respir J. 2021:2100905. Doi:10.1183/13993003.00905-2021
  • Manabe YC, Andrade BB, Gupte N, et al. A parsimonious host inflammatory biomarker signature predicts incident tb and mortality in advanced HIV. Clin Infect Dis. 2020;71(10):2645–2654. doi:10.1093/cid/ciz1147
  • Taneja V. Sex hormones determine immune response. Front Immunol. 2018;9:1931. doi:10.3389/fimmu.2018.01931
  • Gubbels Bupp MR, Jorgensen TN. Androgen-induced munosuppression. Front Immunol. 2018;9:794. doi:10.3389/fimmu.2018.00794